Translated automatically – community improvements welcome.
Alimemazine
Alimemazine is a phenothiazine derivative with sedative and antipsychotic properties. It primarily acts as an H1 antihistamine and additionally blocks dopamine-D2 and muscarinic acetylcholine receptors. Due to its effects, it is used to treat sleep disorders and restlessness. The substance can cause side effects such as sedation and anticholinergic effects.
Mechanism of Action
- D2 antagonist
- H1 antagonist
- muscarinic antagonist
Names / Identifiers
IUPAC: Alimemazine
Mechanism of Action
Alimemazine primarily acts as an antagonist at H1 histamine receptors, leading to sedative effects. Additionally, it blocks dopamine-D2 receptors and muscarinic acetylcholine receptors, which explains its antipsychotic and anticholinergic properties.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Pregnancy
- Breastfeeding
- Known hypersensitivity to phenothiazines
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Sedierung, Schwindel und anticholinerge Effekte.
Safer Use
- Start at low doses
- Be aware of interactions with other medications
Harm reduction tips do not replace medical advice.
Known Interactions
- Alcohol consumption may enhance the sedative effect
- Interactions with other antipsychotics
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.